Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Parecoxib Formulations in Healthy Volunteers
NCT06600282Phase 4Not yet recruiting
- Sponsor
- Yung Shin Pharmaceutical Industry
- Start
- Oct 2024
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of parecoxib in postoperative pain, sponsored by Yung Shin Pharmaceutical Industry. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
parecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06600282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06600282.